Impact of Body Mass Index in the Cardioverter Efficacy of Amiodarone in Persistent Atrial Fibrillation.

Carmen LigeroPau Riera Amine El Amrani Victor Bazan José M Guerra Silvia HerraezXavier ViñolasJosep M Alegret

Published in: Pharmaceuticals (Basel, Switzerland) (2024)

We observed a negative relationship between an increased BMI and the efficacy of amiodarone for reversion to SR, suggesting a negative clinical impact of excess body fat in its efficacy.

Keyphrases

body mass index
atrial fibrillation
weight gain
heart failure
physical activity
percutaneous coronary intervention
coronary artery disease
left atrial appendage
catheter ablation
mitral valve